Skorpios Trust
SEC insider (Form 3/4/5 filer). CIK 0001869333. 10% Owner at Stoke Therapeutics, Inc. (STOK). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2025. Located in LIMASSOL, G4.
Companies Skorpios Trust has filed insider reports for
- Stoke Therapeutics, Inc. (STOK): 10% Owner
Skorpios Trust
CIK: 0001869333
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
STOK
Stoke Therapeutics, Inc.
10% Owner